Hepatocyte growth factor (HGF) in patients with pneumonia: A comparison between survivors and non-survivors

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 4, 1998, Pages 405-409

  Nayeri, Fariba ^a,b   Nilsson, Ingela ^a   Skude, Gunnar ^a   Brudin, Lars ^a   Söderström, Claes ^a  

^a KALMAR COUNTY HOSPITAL   (Sweden)

^b Universitetsjukhuset ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; SCATTER FACTOR;

AGED; ARTICLE; BACTERIAL PNEUMONIA; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; L-LACTATE DEHYDROGENASE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0031767830     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850160729     Document Type: Article

References (25)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatcctomized rats. Biochem Biophys Res Commun 1984; 122: 1450-9.
2. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Takahashi K, Koura M, Hashimoto S. Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 1986; 166: 139-50.
3. Godha E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-9.
4. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T, Kitamura N. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem 1992; 276: 20114-9.
5. Mizuno K, Takehara T, Nakamura T. Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem Biophys Res Commun 1992; 189: 1631-8.
6. Miazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor: structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 1993; 268: 10024-8.
7. Weidner KM, Arakaki N, Hartmann, Vandekerckhove J, Weingart S, Reider H, et al. Evidence of the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001-5.
8. Matsumoto K, Hashimoto K, Yoshikawa K, Nakamura T. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res 1991; 196: 114-20.
9. Tajima H, Matsumoto K, Nakamura T. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 1992; 202: 423-31.
10. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-8.
11. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, Nakamura T. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173: 42-7.
12. Michalopoulos GK. Liver regeneration: molecular mechanism of growth control. FASEB J 1990; 4: 176-87.
13. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991; 3: 67-85.
14. Kinoshita T, Tashiro K, Nakamura T. Marked increase of HGF m-RNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 1989; 165: 1229-34.
15. Hamanoue M, Kawaida K, Takao S, Shimizu H, Noji S, Matsumoto K, Nakamura T. Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology 1992; 16: 1485-92.
16. Kono S, Nagaike M, Matsumoto K, Nakamura T. Marked induction of hepatocyte growth factor mRNA in intact kidney and spleen in response to injury of distant organs. Biochem Biophys Res Commun 1992; 186: 991-8.
17. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration and other biological functions. Crit Rev Oncog 1992; 3: 27-54.
18. Matsumoto K, Tajima H, Hanamoue M, Kohno S, Kinoshita T, Nakamura T. Identification and characterization of "injurin". an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci USA 1992; 89: 3800-4.
19. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 1992; 182: 802-9.
20. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993; 268: 21212-7.
21. Panos RJ, Rubin JS, Aaronson SA, Mason RJ. Keratinocyte growth factor and Hepatocyte growth factor/Scatter factor are heparine-binding growth factors for alveolar type II cells in tibroblast-conditioned medium. J Clin Invest 1993; 92: 969-77.
22. Dahlberg G. Statistical methods for medical and biological students. 2nd edn. London: George Allen & Unwin Ltd., 1940.
23. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992; 16: 1227-35.
24. Maeda J, Ueki N, Hada T, Higashino K. Elevated serum hepatocyte growth factor scatter factor levels in inflammatory lung diseases. Am J Respir Crit Care Med 1995; 152: 1587-91.
25. Ewing S, Bauer T, Hasper E, Pizzulli L, Kubini R, Luderitz B. Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia. Eur Respir J 1995; 8: 392-7.